The association between affordable care act implementation and the prevalence of women having ever received a Pap smear.


Journal

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
ISSN: 1364-6893
Titre abrégé: J Obstet Gynaecol
Pays: England
ID NLM: 8309140

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: ppublish

Résumé

To assess if implementation of the 2010 Patient Protection and Affordable Care Act (ACA) was associated with changes in the prevalence of women having ever received a pap smear. This study utilised the publicly available Centre for Disease Control National Survey of Family Growth (NSFG) data set. This was a serial cross-sectional study. The comparison groups were defined as women who received cancer screening and prevention interventions prior to full implementation of the ACA (2011-2013) and post full implementation (2017-2019). The primary outcome was self-reporting receipt of a Papanicolaou (Pap) smear. Secondary outcomes included HPV vaccination and mammogram rates. Anonymized patient information was collected from the nationally representative dataset, and analyses were performed utilising STATA 18. The two study cohorts obtained from the NSFG included women who responded in 2011-2013 ( A decrease in proportion of women ever having had a Pap smear despite implementation of health policies to increase access to preventive measures suggests further interventions to improve access to cervical cancer screening are warranted. The Patient Protection and Affordable Care Act, which was implemented in 2014, aimed to reform health care access. This serial cross-sectional study demonstrated that the number of women age 21 or older who had ever received a pap smear fell after the implementation of the Patient Protection and Affordable Care Act.

Sections du résumé

BACKGROUND UNASSIGNED
To assess if implementation of the 2010 Patient Protection and Affordable Care Act (ACA) was associated with changes in the prevalence of women having ever received a pap smear.
METHODS UNASSIGNED
This study utilised the publicly available Centre for Disease Control National Survey of Family Growth (NSFG) data set. This was a serial cross-sectional study. The comparison groups were defined as women who received cancer screening and prevention interventions prior to full implementation of the ACA (2011-2013) and post full implementation (2017-2019). The primary outcome was self-reporting receipt of a Papanicolaou (Pap) smear. Secondary outcomes included HPV vaccination and mammogram rates. Anonymized patient information was collected from the nationally representative dataset, and analyses were performed utilising STATA 18.
RESULTS UNASSIGNED
The two study cohorts obtained from the NSFG included women who responded in 2011-2013 (
CONCLUSION UNASSIGNED
A decrease in proportion of women ever having had a Pap smear despite implementation of health policies to increase access to preventive measures suggests further interventions to improve access to cervical cancer screening are warranted.
The Patient Protection and Affordable Care Act, which was implemented in 2014, aimed to reform health care access. This serial cross-sectional study demonstrated that the number of women age 21 or older who had ever received a pap smear fell after the implementation of the Patient Protection and Affordable Care Act.

Autres résumés

Type: plain-language-summary (eng)
The Patient Protection and Affordable Care Act, which was implemented in 2014, aimed to reform health care access. This serial cross-sectional study demonstrated that the number of women age 21 or older who had ever received a pap smear fell after the implementation of the Patient Protection and Affordable Care Act.

Identifiants

pubmed: 39176454
doi: 10.1080/01443615.2024.2393359
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393359

Auteurs

Eric M Ganz (EM)

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.

Benjamin Brown (B)

Department of Obstetrics and Gynecology, Warren Alpert Medical School, Brown University, Providence, RI, USA.

Heather Smith (H)

Department of Obstetrics and Gynecology, Warren Alpert Medical School, Brown University, Providence, RI, USA.

Lawren Wellisch (L)

Brown University School of Public Health, Providence, RI, USA.

Megha Gupta (M)

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.

Stephen M Wagner (SM)

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH